Benefit of converting enzyme inhibition on left ventricular volumes and ejection fraction in patients receiving β-blockade after myocardial infarction

American Heart Journal

Volumn 132, Issue 1 I, 1996, Pages 71-77

  Bonarjee, V V S ^a   Carstensen, S ^a   Caidahl, K ^a   Nilsen, D W T ^a   Edner, M ^a   Lindvall, K ^a   Snapinn, S M ^a   Berning, J ^a  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; ENALAPRILAT; FIBRINOLYTIC AGENT; GLYCERYL TRINITRATE; PLACEBO;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ECHOCARDIOGRAPHY; ENZYME INHIBITION; FEMALE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE VOLUME; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0029958453     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(96)90392-0     Document Type: Article

References (0)